Evidence map›Paper›PMID 31273262›Full record

ArticleScientific reports2019

ABO blood group A transferase and its codon 69 substitution enzymes synthesize FORS1 antigen of FORS blood group system.

Miyako Yamamoto, Maria Cristina Tarasco, Emili Cid, Hidetomo Kobayashi, Fumiichiro Yamamoto

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 3 countries.

Miyako YamamotoLaboratory of Immunohematology and Glycobiology, Josep Carreras Leukaemia Research Institute (IJC), Campus Can Ruti, Camí de les Escoles, Badalona, Barcelona, 08916, Spain.ORCID http://orcid.org/0000-0001-9516-1402
Maria Cristina TarascoLaboratory of Immunohematology and Glycobiology, Josep Carreras Leukaemia Research Institute (IJC), Campus Can Ruti, Camí de les Escoles, Badalona, Barcelona, 08916, Spain.
Emili CidLaboratory of Immunohematology and Glycobiology, Josep Carreras Leukaemia Research Institute (IJC), Campus Can Ruti, Camí de les Escoles, Badalona, Barcelona, 08916, Spain.ORCID http://orcid.org/0000-0002-5025-352X
Hidetomo KobayashiLaboratory of Immunohematology and Glycobiology, Josep Carreras Leukaemia Research Institute (IJC), Campus Can Ruti, Camí de les Escoles, Badalona, Barcelona, 08916, Spain.
Fumiichiro YamamotoLaboratory of Immunohematology and Glycobiology, Josep Carreras Leukaemia Research Institute (IJC), Campus Can Ruti, Camí de les Escoles, Badalona, Barcelona, 08916, Spain. fyamamoto@carrerasresearch.org.ORCID http://orcid.org/0000-0001-9690-7034
Josep Carreras Leukaemia Research Institute · ESUniversity of Parma · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human histo-blood group A transferase (AT) catalyzes the biosynthesis of oligosaccharide A antigen important in blood transfusion and cell/tissue/organ transplantation. This enzyme may synthesize Forssman antigen (FORS1) of the FORS blood group system when exon 3 or 4 of the AT mRNA is deleted and/or the LeuGlyGly tripeptide at codons 266-268 of AT is replaced by GlyGlyAla. The Met69Ser/Thr substitutions also confer weak Forssman glycolipid synthase (FS) activity. In this study, we prepared the human AT derivative constructs containing any of the 20 amino acids at codon 69 with and without the GlyGlyAla substitution, transfected DNA to newly generated COS1(B3GALNT1 + A4GALT) cells expressing an enhanced level of globoside (Gb4), the FS acceptor substrate, and immunologically examined the FORS1 expression. Our results showed that all those substitution constructs at codon 69 exhibited FS activity. The combination with GlyGlyAla significantly increased the activity. The conserved methionine residue in the ABO, but not GBGT1, gene-encoded proteins may implicate its contribution to the separation of these genes in genetic evolution. Surprisingly, with increased Gb4 availability, the original human AT with the methionine residue at codon 69 was also demonstrated to synthesize FORS1, providing another molecular mechanism of FORS1 appearance in cancer of ordinary FORS1-negative individuals.

Indexed as

CodonABO Blood-Group SystemAmino Acid SubstitutionAntigens, SurfaceBlood Group AntigensHeLa CellsHumansN-AcetylgalactosaminyltransferasesTransferasesABO Blood-Group Systemantigen FORSE-1Antigens, SurfaceBlood Group AntigensCodonGBGT1 protein, humanN-AcetylgalactosaminyltransferasesTransferases

Identifiers

PMID31273262
PMCPMC6609624
OpenAlexW2954975742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.